Log in

Start Your Membership Now

Aspire Universal (Aspire) recently launched a $300 million fund—the Aspire Ventures Precision Medicine Fund (AVP)—for investment in technology to support precision medicine. Lancaster General Health is a general partner in the fund, which builds upon a pre-existing collaboration between Aspire and Lancaster General Health.

Specifically, the fund will invest in AI development companies, as well as support technology being developed by the Smart Health Innovation Lab, a collaborative effort formed in 2017 by Aspire, Lancaster General Health, and capital BlueCross. AVP selects eight start-ups per year for a 12-week intensive certification process, expediting insurance reimbursement . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Service & Treatment Updates

Categories
All Bulletins
Submit a Bulletin
  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.